| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Sep 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.02M | 4.16M | 7.81M | 12.42M | 8.36M |
| Gross Profit | 864.00K | 1.29M | 3.52M | 5.20M | 3.34M |
| EBITDA | -2.82M | -4.13M | -2.37M | -325.00K | -1.31M |
| Net Income | -3.63M | -4.60M | -2.85M | -805.00K | -1.66M |
Balance Sheet | |||||
| Total Assets | 7.52M | 8.46M | 11.60M | 12.45M | 12.76M |
| Cash, Cash Equivalents and Short-Term Investments | 2.02M | 374.00K | 4.12M | 2.81M | 5.44M |
| Total Debt | 366.00K | 544.00K | 643.00K | 725.00K | 653.00K |
| Total Liabilities | 2.80M | 2.90M | 2.84M | 3.63M | 3.31M |
| Stockholders Equity | 4.71M | 5.56M | 8.76M | 8.82M | 9.45M |
Cash Flow | |||||
| Free Cash Flow | -701.00K | -4.90M | -1.45M | -2.63M | -2.31M |
| Operating Cash Flow | -273.00K | -4.36M | -826.00K | -2.51M | -1.58M |
| Investing Cash Flow | -454.00K | -450.00K | -532.00K | -112.00K | -735.00K |
| Financing Cash Flow | 2.37M | 1.05M | 2.65M | -50.00K | 491.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £33.54M | 946.52 | 8.48% | 2.09% | 22.02% | 15.56% | |
68 Neutral | £2.13B | 20.86 | 19.34% | 2.00% | -0.47% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £9.16M | 13.59 | 4.23% | 3.20% | 10.89% | 9.05% | |
57 Neutral | £5.77M | -1,417.91 | -8.19% | ― | 24.39% | 65.82% | |
54 Neutral | £2.94M | 14.33 | -21.12% | ― | 20.42% | ― | |
42 Neutral | £3.13M | -0.33 | -76.54% | ― | 44.63% | 59.14% |